Restricted Council - Two-Hundred-and-Twenty-First Session

Europe/Zurich
503/1-001 - Council Chamber (CERN)

503/1-001 - Council Chamber

CERN

162
Show room on map
    • Restricted Council
      • 1
        Report on the credentials
      • 2
        Matters arising from the previous meeting
      • 3
        Adoption of the agenda
      • 4
        Approval of the draft minutes of the two-hundred-and-twentieth Session - Restricted Council
      • 5
        President’s report (Oral)
      • 6
        Director-General’s report (Oral)
      • 7
        Major safety incident report (Mr B. Delille - Oral)
      • 8
        Developments in the Member and Associate Member States relevant for CERN
      • 9
        Scientific Policy Committee
        • a) Report by the Chair of the Scientific Policy Committee (Dr H. Montgomery - Oral)
        • b) Questions to the Scientific Policy Committee
      • 10
        Finance Committee
        • a) Report by the Chair of the Finance Committee (Dr L. Salzarulo - Oral)
        • b) Questions to the Finance Committee
      • 10:50
        Coffee break
      • 11
        CERN Annual Progress Report 2024 (Mr R. Bello)
      • 12
        Audit Committee (AC)
        • a) Key messages from the AC meeting held on 25 February 2025
        • b) AC – Annual activity report 2024
        • c) Questions to the Audit Committee
      • 13
        CERN Pension Fund
        • a) Report by the Chair of the Pension Fund Governing Board (Dr F. Buzatu - Oral)
        • b) Report of the Pension Fund Governing Board on the Definition of Full Funding
      • 12:55
        Lunch
      • 14
        Annual Fundraising Report (Ms C. Warakaulle - Oral)
      • 15
        FCC Feasibility Study
      • 16
        Report on non-LHC experiments (Professor J. Mnich - Oral)
      • 15:35
        Tea break
      • 17
        LHC and HL-LHC matters
        • a) Status of the accelerator complex and upgrade (Dr M. Lamont - Oral)
        • b) Status report on the LHC experiments and computing (Professor J. Mnich - Oral)
      • 18
        Use of MEDICIS isotopes for clinical treatment (Dr M. Lamont)
      • 19
        Report on ESPP status (Professor P. Sphicas - Oral)
      • 20
        Report from the LDG (Professor M. Seidel)
      • 21
        Confirmation of the access status of the documents on the agenda (Oral)
      • 22
        Other business